BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7902814)

  • 1. Comparison of responses to pituitary adenylate cyclase activating peptides 38 and 27 in the pulmonary vascular bed of the cat.
    Cheng DY; McMahon TJ; Dewitt BJ; Carroll GC; Lee SS; Murphy WA; Bitar KG; Coy DH; Kadowitz PJ
    Eur J Pharmacol; 1993 Oct; 243(1):79-82. PubMed ID: 7902814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of responses to pituitary adenylate cyclase activating polypeptide-38 in the feline hindquarters vascular bed.
    Santiago JA; Kadowitz PJ
    Eur J Pharmacol; 1993 Oct; 243(3):291-4. PubMed ID: 7903943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of cardiovascular responses to PACAP-27, PACAP-38, and vasoactive intestinal polypeptide.
    Champion HC; Santiago JA; Garrison EA; Cheng DY; Coy DH; Murphy WA; Ascuitto RJ; Ross-Ascuitto NT; McNamara DB; Kadowitz PJ
    Ann N Y Acad Sci; 1996 Dec; 805():429-41; discussion 442. PubMed ID: 8993422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of PACAP and VIP on the pulmonary and hindquarters vascular beds of the cat.
    Minkes RK; McMahon TJ; Hood JS; Murphy WA; Coy DH; McNamara DB; Kadowitz PJ
    J Appl Physiol (1985); 1992 Mar; 72(3):1212-7. PubMed ID: 1568976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of systemic and pulmonary vascular responses to PACAP and VIP: role of adrenal catecholamines.
    Minkes RK; McMahon TJ; Higuera TR; Murphy WA; Coy DH; Kadowitz PJ
    Am J Physiol; 1992 Dec; 263(6 Pt 2):H1659-69. PubMed ID: 1481892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary vasodilator responses to vasoactive intestinal peptide in the cat.
    Nandiwada PA; Kadowitz PJ; Said SI; Mojarad M; Hyman AL
    J Appl Physiol (1985); 1985 May; 58(5):1723-8. PubMed ID: 3997734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
    Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular effects of pituitary adenylate cyclase activating peptide: a comparison with vasoactive intestinal peptide.
    Absood A; Chen D; Wang ZY; Håkanson R
    Regul Pept; 1992 Aug; 40(3):323-9. PubMed ID: 1332142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
    Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
    Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary adenylate cyclase-activating peptide 38 a potent endogenously produced dilator of human airways.
    Kinhult J; Andersson JA; Uddman R; Stjärne P; Cardell LO
    Eur Respir J; 2000 Feb; 15(2):243-7. PubMed ID: 10706486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct receptors mediate pituitary adenylate cyclase-activating peptide- and vasoactive intestinal peptide-induced relaxation of rat ileal longitudinal muscle.
    Ekblad E; Sundler F
    Eur J Pharmacol; 1997 Sep; 334(1):61-6. PubMed ID: 9346329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38) on tissue oxygen content--treatment in central nervous system of mice.
    Ohtaki H; Dohi K; Yofu S; Nakamachi T; Kudo Y; Endo S; Aruga T; Goto N; Watanabe J; Kikuyama S; Shioda S
    Regul Pept; 2004 Dec; 123(1-3):61-7. PubMed ID: 15518894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Backup Mechanisms Maintain PACAP/VIP-Induced Arterial Relaxations in Pituitary Adenylate Cyclase-Activating Polypeptide-Deficient Mice.
    Ivic I; Fulop BD; Juhasz T; Reglodi D; Toth G; Hashimoto H; Tamas A; Koller A
    J Vasc Res; 2017; 54(3):180-192. PubMed ID: 28490016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasodilator effect of pituitary adenylate cyclase activating polypeptide (PACAP) on femoral blood flow in dogs.
    Naruse S; Suzuki T; Ozaki T; Nokihara K
    Peptides; 1993; 14(3):505-10. PubMed ID: 8101368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
    Nagakawa O; Junicho A; Akashi T; Koizumi K; Matsuda T; Fuse H; Saiki I
    Oncol Rep; 2005 Jun; 13(6):1217-21. PubMed ID: 15870945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence and effects of pituitary adenylate cyclase activating peptide in the submandibular gland of the ferret.
    Tobin G; Asztély A; Edwards AV; Ekström J; Håkanson R; Sundler F
    Neuroscience; 1995 May; 66(1):227-35. PubMed ID: 7637871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution and effects of pituitary adenylate cyclase activating peptide in cat and human lower oesophageal sphincter.
    Ny L; Larsson B; Alm P; Ekström P; Fahrenkrug J; Hannibal J; Andersson KE
    Br J Pharmacol; 1995 Dec; 116(7):2873-80. PubMed ID: 8680719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.